DocGo Inc. (NASDAQ:DCGO) is P.A.W. Capital Corp’s 3rd Largest Position

P.A.W. Capital Corp decreased its stake in DocGo Inc. (NASDAQ:DCGO) by 1.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,600,000 shares of the company’s stock after selling 30,000 shares during the quarter. DocGo makes up 12.9% of P.A.W. Capital Corp’s portfolio, making the stock its 3rd biggest holding. P.A.W. Capital Corp owned 1.57% of DocGo worth $6,784,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Rhumbline Advisers grew its position in shares of DocGo by 4.5% during the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock worth $605,000 after purchasing an additional 6,204 shares in the last quarter. WCM Investment Management LLC grew its position in shares of DocGo by 64.2% during the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock worth $18,637,000 after purchasing an additional 1,687,100 shares in the last quarter. Matrix Asset Advisors Inc. NY purchased a new stake in shares of DocGo during the fourth quarter worth about $424,000. SG Americas Securities LLC grew its position in shares of DocGo by 12.9% during the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock worth $183,000 after purchasing an additional 4,905 shares in the last quarter. Finally, Harbor Capital Advisors Inc. grew its position in shares of DocGo by 37.5% during the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock worth $5,647,000 after purchasing an additional 363,391 shares in the last quarter. Hedge funds and other institutional investors own 56.44% of the company’s stock.

Insider Activity at DocGo

In related news, General Counsel Ely D. Tendler sold 23,088 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the transaction, the general counsel now directly owns 175,645 shares of the company’s stock, valued at approximately $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reiterated a “buy” rating and set a $7.00 target price on shares of DocGo in a research report on Thursday, January 16th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $6.10.

DocGo Trading Down 4.8 %

Shares of DocGo stock opened at $4.79 on Friday. The stock has a 50 day moving average of $4.63 and a 200 day moving average of $4.00. DocGo Inc. has a 12 month low of $2.75 and a 12 month high of $5.68. The firm has a market cap of $488.82 million, a PE ratio of 17.11, a PEG ratio of 14.16 and a beta of 1.00.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.